Submit Deal

PARATEK PHARMACEUTICALS

HQ - Boston, MA

Summary

Paratek Pharmaceuticals is a commercial-stage biopharmaceutical company.

Deals Overview

Total Deals2

Valued Deals2

Total Value£ 626 M

Avg. Deal Size£ 313 M

Market Context

Senior Management

Sort

paratek pharmaceuticals

HQ - United States

Pharmaceuticals

21 Sep 2023

Investment Date

100%

Stake

£ 371 M

Deal Value

optinose inc

HQ - United States

Pharmaceuticals

21 May 2025

Investment Date

100%

Stake

£ 254 M

Deal Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy